Kristenn J

Biography

Luigi Costa has more than 20 years of experience in the international pharmaceutical and biotechnology industry. Previously, he held the position of vice president Europe, Middle East and Africa at Onyx Pharmaceuticals, a global biopharmaceutical company based in San Francisco, California where he was responsible for building the company’s international organisation and for the prelaunch and launch of its haematology product, Kyprolis, in over 50 countries outside the USA. Prior to joining Onyx Pharmaceuticals, Mr Costa held several executive positions at Amgen including head of International Oncology Franchise and managing director of Italy and France. He also held various leadership positions with Eli Lilly in the US and Europe. He currently serves as director of the board of Oncopeptides AB. Mr Costa holds a BSc in business administration and an MBA from Bocconi Business School. He has served as chief executive officer of Nordic Nanovector since September 2014.   Luigi Costa has more than 20 years of experience in the international pharmaceutical and biotechnology industry. Previously, he held the position of vice president Europe, Middle East and Africa at Onyx Pharmaceuticals, a global biopharmaceutical company based in San Francisco, California where he was responsible for building the company’s international organisation and for the prelaunch and launch of its haematology product, Kyprolis, in over 50 countries outside the USA. Prior to joining Onyx Pharmaceuticals, Mr Costa held several executive positions at Amgen including head of International Oncology Franchise and managing director of Italy and France. He also held various leadership positions with Eli Lilly in the US and Europe. He currently serves as director of the board of Oncopeptides AB. Mr Costa holds a BSc in business administration and an MBA from Bocconi Business School. He has served as chief executive officer of Nordic Nanovector since September 2014.  

Research Interest

Oncology